MoneyWorks4Me

Innova Captab - Quaterly Results

05 Feb 2025 Evaluate
The Revenue for the quarter ended  December 2024 of Rs. 2485.25 millions grew by 5.10 % from Rs. 2364.60 millions.An average growth of 30.83% was recorded for the quarter ended December 2024 to Rs. 244.02  millions from Rs. 186.51 millions.OP of the company witnessed a marginal growth to 359.85 millions from 322.91 millions in the same quarter last year.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202412 202312 % Var 202412 202312 % Var 202403 202303 % Var
Sales 2485.25 2364.60 5.10 7155.39 6668.27 7.31 8649.29 8586.73 0.73
Other Income 34.94 17.72 97.18 124.19 47.10 163.67 107.18 87.34 22.72
PBIDT 359.85 322.91 11.44 1065.38 892.91 19.32 1186.88 1072.63 10.65
Interest 1.33 38.13 -96.51 2.99 134.71 -97.78 135.91 183.00 -25.73
PBDT 358.52 284.78 25.89 1062.39 758.20 40.12 1050.97 889.63 18.14
Depreciation 30.79 29.70 3.67 92.03 84.70 8.65 113.99 106.56 6.97
PBT 327.73 255.08 28.48 970.36 673.50 44.08 936.98 783.07 19.65
TAX 83.71 68.57 22.08 246.91 189.09 30.58 255.37 207.55 23.04
Deferred Tax 20.89 2.45 752.65 54.32 6.10 790.49 3.53 18.94 -81.36
PAT 244.02 186.51 30.83 723.45 484.41 49.35 681.61 575.52 18.43
Equity 572.25 572.25 0.00 572.25 572.25 0.00 572.25 480.00 19.22
PBIDTM(%) 14.48 13.66 6.03 14.89 13.39 11.19 13.72 12.49 9.85
Peers
Company Name CMP
Sun Pharma. Inds. 1842.00
Dr. Reddys Labs. 1161.00
Cipla 1365.00
Lupin 2096.00
Zydus Lifesciences 1119.50
View more..